Dr. Andrew L. Smith (MD, FRCPC) is an early-career academic psychiatrist at The Ottawa Hospital (TOH), an Assistant Professor at the University of Ottawa Faculty of Medicine, and a Clinician Investigator in the Neuroscience Program at the Ottawa Hospital Research Institute (OHRI). He has a Graduate Diploma in Clinical Epidemiology from Memorial University of Newfoundland and a Certificate of Specialization in Business Applications of AI in Healthcare from Harvard School of Public Health. Dr. Smith has peer-reviewed publications in the areas of olfactory learning, artificial intelligence, and novel psychoactive substances. Dr. Smith's research interests include novel therapeutics, efficient healthcare delivery, consciousness, virtual and mixed reality in mental health, and the ethical use of artificial intelligence. He has ongoing personal projects in the fields of literature, art, and design. Dr. Smith is the Chief Medical Officer (CMO) for BioEquity Holdings, Co-Founder and CMO for PsychPartners Inc., and has served in various leadership roles within the University of Ottawa and The Ottawa Hospital, including his current position on the Board of Directors of TOHAMO. Dr. Smith is a member of the Society for Medical Decision Making and the Association for the Scientific Study of Consciousness.

Lab Memberships: SCIENCES Lab